RELMADA THERAPEUTICS, INC. - Common Stock (RLMD)

CUSIP: 75955J402

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+31,126,614
Put/Call ratio
14%
SEC-reported price per share
$6.96
Number of holders
102
Value change
+$220,722,088
Number of buys
59
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
105,041,614

Security key

75955J402

Report period

Q1 2026

Institutions

102

Top holders

10

Ownership snapshot

Top reported holders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F Lead comparable stake: 10% 13D/G row: Janus Henderson Group Ltd. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership Top 5
Janus Henderson Group Ltd. 10%
Squadron Capital Management LLC 9.9%
Spruce Street Capital LP 5.6%
Ikarian Capital, LLC 4.8%
Adage Capital Management, L.P. 4.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13D/G 13F
JANUS HENDERSON GROUP PLC · Company
10%
$35,932,374
7,439,415 shares
$0 30 Jan 2026
Squadron Capital Management LLC
13F 13D/G
Company · Squadron Master Fund LP
9.9%
from 13D/G
$32,361,000
6,700,000 shares
31 Dec 2025
Spruce Street Capital LP
13F 13D/G
Company
5.6%
from 13D/G
$19,736,254
4,086,181 shares
31 Dec 2025
Ikarian Capital, LLC
13F 13D/G
Company
4.8%
from 13D/G
$14,820,175
3,068,359 shares
31 Dec 2025
Adage Capital Management, L.P.
13D/G
4.5%
$35,152,106
4,763,158 shares
+$3,639,506 31 Mar 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
4.1%
$20,624,100
4,270,000 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
102
Shares
84,720,353
Rows available
102
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
102
Q1 2026 holders
102
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .